NUVB (Nuvation Bio) Total Operating Expense: $280.0 Mil (TTM As of Mar. 2026)


NUVB Nuvation Bio Inc NUVB
33 GF Score
Price $5.81
! 3 Warning Signs
View Full Analysis

What is Nuvation Bio Total Operating Expense?

Nuvation Bio NUVB -4.91% 33 Total Operating Expense is $280.0 Mil as of Mar. 2026. GuruFocus rates NUVB with a GF Score™ of 33/100. The stock has 3 warning signs investors should review.

Nuvation Bio's Total Operating Expense for the three months ended in Mar. 2026 was $73.4 Mil. Nuvation Bio's Total Operating Expense for the trailing twelve months (TTM) ended in Mar. 2026 was $280.0 Mil.

Nuvation Bio Total Operating Expense Related Terms

Nuvation Bio Total Operating Expense Historical Data

* Premium members only.

The historical data trend for Nuvation Bio's Total Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Nuvation Bio Total Operating Expense Chart

Nuvation Bio Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Operating Expense
Get a 7-Day Free Trial 93.32 119.73 99.82 168.35 266.67

Nuvation Bio Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 59.99 65.85 66.21 74.62 73.36
NUVB
33GF Score
Nuvation Bio Inc NUVB
Total Operating Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Nuvation Bio Total Operating Expense Calculation

Total Operating Expense is the primary recurring expense associated with central operations that are incurred in order to generate sales.


Total Operating Expense for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $280.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Total Operating Expense of $280.0 Mil mean?
Nuvation Bio (NUVB) has a Total Operating Expense of $280.0 Mil as of Mar. 2026. Total operating expense is the primary recurring expense associated with central operations. View historical data on Nuvation Bio and its competitors.
Is Nuvation Bio's Total Operating Expense too high?
Nuvation Bio's current Total Operating Expense is $280.0 Mil. Overall, Nuvation Bio has a GF Score™ of 33/100, reflecting its overall financial health beyond just this single metric.
How does Nuvation Bio's Total Operating Expense compare to VRDN and STOK?
Nuvation Bio's Total Operating Expense of $280.0 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Operating Expense for a Biotechnology company?
A good Total Operating Expense depends on the Biotechnology industry context. However, Total Operating Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Operating Expense mean?
A high Total Operating Expense can signal that a stock is expensive relative to its fundamentals. Total operating expense is the primary recurring expense associated with central operations. View historical data on Nuvation Bio and its competitors. Nuvation Bio's current Total Operating Expense is $280.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nuvation Bio stock overvalued right now?
Nuvation Bio (NUVB) has a current Total Operating Expense of $280.0 Mil. The current Total Operating Expense is $280.0 Mil. Nuvation Bio's overall GF Score™ is 33/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Operating Expense calculated?
Total Operating Expense is calculated from a company's financial statements. For Nuvation Bio (NUVB), the current Total Operating Expense is $280.0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Nuvation Bio Business Description

Other Exchanges 1E30:Germany
Address 1500 Broadway, Suite 1401, New York, NY, USA, 10036
Nuvation Bio Inc is a biopharmaceutical company tackling unmet needs in oncology by developing differentiated and novel therapeutic candidates. Its product candidate, taletrectinib, is an oral, potent, central nervous system-active, selective, next-generation c-ros oncogene 1 (ROS1) inhibitor designed for the treatment of patients with ROS1+ non-small cell lung cancer (NSCLC). In addition, its clinical-stage pipeline includes oncology product candidates such as Safusidenib, NUV-1511, and NUV-868 in different stages of development. The Company generates revenue from out-licensing collaborative agreements, including product revenue, upfront license fees, royalty revenue, and research and development services revenue. The Company generates the majority of its revenue from Japan.
33GF Score

Get the complete analysis for NUVB

Total Operating Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$5.81
Price